Story
Cardinal Health Shares Climb After Extending CVS Distribution Deal to 2032
Cardinal Health Inc. (NYSE:CAH) shares rose sharply in Thursday trading after the company announced a significant, long-term extension of its pharmaceutical distribution agreement with CVS Health. The news provides investors with greater certainty over a key revenue stream, bolstering confidence in the company's financial outlook.
Deal Details
Cardinal Health announced it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health. The contract, which maintains its current scope of services, is now set to run through June 30, 2032.
"We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," said Jason Hollar, CEO of Cardinal Health, in a company statement.
Market Reaction and Financial Outlook
AdFollowing the announcement, shares of Cardinal Health climbed 3.7%. The contract extension provides significant long-term revenue visibility, a key factor for market sentiment.
In connection with the deal, Cardinal Health reaffirmed its key financial targets, including:
- Fiscal year 2027 non-GAAP EPS growth guidance of 13% to 15%, or $12.40 to $12.60 per share.
- A long-term non-GAAP EPS growth rate target of 12% to 14%.
The company stated that it may provide further updates during its upcoming first-quarter earnings call, scheduled for November 5, 2026.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.